About us
Our aim is to create the first in Russia (in the special economic zone “Dubna”) independent Center for preclinical studies in accordance with international and Russian standards. This Center will initially provide preclinical services to world leaders of pharmaceutical industry, bio-medical companies, as well as to other companies, whose products and technologies must undergo preclinical trials and safety evaluation prior to their market entrance. Bonasana’s testing will focus on drugs, substances and materials, containing nanoparticles as well as safety evaluation of medical products and diagnostic test systems.
